Avantor, Inc. (NYSE:AVTR) Shares Bought by US Bancorp DE

US Bancorp DE raised its position in shares of Avantor, Inc. (NYSE:AVTRGet Rating) by 7.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 37,721 shares of the company’s stock after acquiring an additional 2,506 shares during the quarter. US Bancorp DE’s holdings in Avantor were worth $739,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the company. Cigna Investments Inc. New raised its holdings in shares of Avantor by 6.7% during the second quarter. Cigna Investments Inc. New now owns 6,679 shares of the company’s stock valued at $208,000 after acquiring an additional 419 shares during the last quarter. Cibc World Market Inc. increased its holdings in shares of Avantor by 1.3% in the first quarter. Cibc World Market Inc. now owns 36,082 shares of the company’s stock valued at $1,220,000 after purchasing an additional 480 shares during the last quarter. AE Wealth Management LLC increased its holdings in shares of Avantor by 1.5% in the second quarter. AE Wealth Management LLC now owns 35,189 shares of the company’s stock valued at $1,094,000 after purchasing an additional 520 shares during the last quarter. Sheaff Brock Investment Advisors LLC increased its holdings in shares of Avantor by 1.5% in the second quarter. Sheaff Brock Investment Advisors LLC now owns 40,829 shares of the company’s stock valued at $1,270,000 after purchasing an additional 616 shares during the last quarter. Finally, Yousif Capital Management LLC increased its holdings in shares of Avantor by 7.9% in the first quarter. Yousif Capital Management LLC now owns 8,870 shares of the company’s stock valued at $300,000 after purchasing an additional 650 shares during the last quarter. Institutional investors and hedge funds own 88.80% of the company’s stock.

Insider Activity

In related news, CFO Thomas A. Szlosek acquired 12,500 shares of Avantor stock in a transaction dated Wednesday, November 16th. The shares were acquired at an average cost of $20.71 per share, for a total transaction of $258,875.00. Following the completion of the purchase, the chief financial officer now owns 35,668 shares in the company, valued at $738,684.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Avantor news, CEO Michael Stubblefield purchased 15,000 shares of the business’s stock in a transaction on Wednesday, November 16th. The shares were bought at an average cost of $20.95 per share, for a total transaction of $314,250.00. Following the completion of the purchase, the chief executive officer now directly owns 429,500 shares in the company, valued at $8,998,025. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Thomas A. Szlosek purchased 12,500 shares of the business’s stock in a transaction on Wednesday, November 16th. The stock was acquired at an average price of $20.71 per share, for a total transaction of $258,875.00. Following the completion of the purchase, the chief financial officer now owns 35,668 shares of the company’s stock, valued at $738,684.28. The disclosure for this purchase can be found here. Insiders own 1.60% of the company’s stock.

Avantor Trading Up 1.6 %

AVTR opened at $23.02 on Friday. Avantor, Inc. has a 52 week low of $17.91 and a 52 week high of $38.83. The business has a fifty day simple moving average of $21.34 and a 200-day simple moving average of $23.46. The firm has a market cap of $15.52 billion, a P/E ratio of 24.49 and a beta of 1.36. The company has a quick ratio of 1.07, a current ratio of 1.65 and a debt-to-equity ratio of 1.29.

Avantor (NYSE:AVTRGet Rating) last released its quarterly earnings results on Friday, October 28th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.33 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.85 billion. Avantor had a return on equity of 24.67% and a net margin of 8.38%. The company’s quarterly revenue was up 1.2% on a year-over-year basis. During the same period last year, the business posted $0.35 earnings per share. On average, equities analysts expect that Avantor, Inc. will post 1.39 earnings per share for the current year.

Analysts Set New Price Targets

AVTR has been the subject of several recent research reports. The Goldman Sachs Group cut their price target on Avantor from $37.00 to $32.00 and set a “buy” rating for the company in a report on Thursday, October 13th. Barclays cut their price target on Avantor from $25.00 to $23.00 and set an “overweight” rating for the company in a report on Monday, October 31st. Morgan Stanley cut their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 31st. Credit Suisse Group cut their price target on Avantor from $32.00 to $25.00 and set a “neutral” rating for the company in a report on Monday, October 31st. Finally, Citigroup lowered their price objective on Avantor from $28.00 to $25.00 in a research report on Monday, October 31st. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $28.47.

Avantor Profile

(Get Rating)

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.